A “rushed” screening process of foreign scientists by the Biden administration sparked concerns from the Government ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

Lon G. von Hurwitz, who will serve as chief strategist and senior advisor, brings 30-plus years of leadership experience in healthcare innovation, marketing, and public health initiatives and will ...